Çocuklarda Wilson Hastalığı

1. Wilson SAK. Progressive lenticular degeneration: A familial
nervous disease associated with cirrhosis of the liver. Brain
1912; 34: 295-509.
2. Hall HC. La degenerescence hepatico-lenticulaire malade de
Wilson-pseudo-sclerose: Paris. Mason and Cie, 1921.
3. Scheinberg IH, Sternlieb I. Wilson’s disease. Philadelphia,
WB Saunders, 1984.
4. Feldstein AE, Chitkara DK, Plescow R, Grand RJ. Wilson
Disease in Pediactric Gastrointestinal Disease by Walker WA.
2004 IV.Ed., BC Decker Inc, Ontario, 1440-54.
5. Mercer FBJ, Lilanos RM. J Nutr, 133: 1481S-1484S, 2003,
Supplement: 11
th
International Symposium on Trace Elements
in Man and Animals. T. Başarır Özkan
170
6. Loudianos G, Gitlin JD. Wilson’s disease. Semin Liver Dis
2000; 20: 353-64.
7. Schilsky ML, Stockert RJ, Sternlieb I. Pleiotropic effect of
LEC mutation: A rodent model of Wilson’s disease. Am J
Physiol 1994; 266: G907-13.
8. Teckman JH, Perlmutter DH. Metabolic Disorders of the
Liver in Pediatric Gastrointestinal Disease by Wyllie R,
Hyams JS. 1999, II Ed., WB Saunders Company,
Philadelphia, 579-99.
9. Barrow L, Tanner MS. Copper distribution among serum
proteins in paediatric liver disorders and malignancies. Eur
J.Clin Invest. 1988; 18: 555-60.
10. Strickland GT, Beckner WM, Leu ML. Absorbtion of copper
in homozygotes and heterozygotes for Wilson’s disease and
controls: Isotope tracer studies with 67 Cu and 64 Cu. Clin Sci
1972; 43: 617-25.
11. Shimuzu N. Wilson disease. Nippon Rinsho 2002; 60, Supp 4:
433-6.
12. Doering EJ III, Savage RA. Hemolysis, coagulation defects
and fulminant hepatic failure as a presentation of Wilson’s
disease. A J Dis Child 1979;133: 440-1.
13. Polio J, Enriquez RE. Hepatocellular carcinoma in Wilson’s
disease. Case report and review of the literature. J Clin
Gastroenterol 1989; 11: 220-4.
14. Feist D, Wesch H, Schmid-Ruter E. Early diagnosis of
Wilson’s disease in childhood. Monatssch Kinderheilkd 1978;
126: 371-4.
15. Yüce A, Koçak N, Gürakan F. Wilson’s disease with hepatic
presentation in childhood. Indian Pediatr 2000; 37: 31-6.
16. Williams FJ, Walsche JM. Wilson’s disease. Brain 1981;
104:735-52.
17. Harik SI, Post MJ. Computed tomografphy in Wilson disease.
Neurology 1981; 31: 107-10.
18. Buchman AL. PET scanning as a diagnostic tool in Wilson’s
disease. Gastroenterology 1998; 114: 227-8.
19. Goldstein NP, Ewert JC. Psychiatric aspects of Wilson’s
disease. Psychiatry 1968; 124: 1555-61.
20. Davison K. Schizophrenia-like psychoses associated with
organic cerebral disorders; A review. Psychiatr. Dev. Spring
1983; 1: 1-33.
21. Wiebers DO, Hollenhorst RW The ophtalmologic
manifestations of Wilson’s disease. Mayo Clin Proc 1977; 52:
409-16.
22. Sanchez-Albisua I. A high index of suspicion. JPGN 2000; 31:
93.
23. Fleming CR, Dickson ER. Pigmented corneal rings in non
Wilsonian liver disease. Ann Intern Med 1977; 86: 285-8.
24. Fleming CR, Dickson ER. Pigmented corneal rings in a
patient with primary biliary cirrhosis Gastroenterology 1975;
69: 220-5.
25. Kuan P. Cardiac Wilson’s disease-Chest 1987; 91: 579-83.
26. Factor SM, Cho S. The cardiomyopathy of Wilson’s disease.
Virchows Arch 1982; 397: 301-11.
27. Wiebers DO, Wilson DM. Renal stones in Wilson’s disease.
Am J Med 1979; 67:249-54.
28. Reynolds ES, Tanner R. The renal lesion in Wilson’s disease.
Am J Med 1966; 48: 518-27.
29. Walshe JM. Effect of penicillamine on failure of renal
acidification in Wilson’s disease. Lancet 1968; i: 775-8.
30. Mindelzun R, Elkin M. Skeletal changes in Wilson’s disease.
Radiology 1970; 94: 127-32.
31. Paterson CR, Losowsky MS. The bones in chronic liver
disease. Scand J Gastroenterol 1967; 2: 293-300.
32. Menerey KA, Eider W. The arthropathy of Wilson’s disease:
Clinical and pathologic features. J Rheumatol 1988; 15: 331-
7.
33. Meyer RJ, Zalusky R. The mechanism of hemolysis in
Wilson’s disease. Mt Sinai J Med 1977; 44: 530-8.
34. Rosenfield N, Grand RJ. Cholelithiasis and Wilson disease. J
Pediatr 1978; 92: 210-3.
35. Dorney SF. Wilson’s disease in childhood. Med J Aust 1986;
145: 538-41.
36. Sternlieb I. Mitochondrial and fatty changes in hepatocytes of
patients with Wilson’s disease. Gastroenterology 1968; 55:
354-67.
37. Sumithran E. Copper-binding protein in liver cells. Hum
Pathol; 16: 1985, 677-82.
38. Brewer GJ. Diagnosis of Wilson’s disease 2002. Gut; 50:136.
39. Sternlieb I, Scheinberg IH. The role of radiocopper in the
diagnosis of Wilson’s disease. Gastroenterology 1979; 77:
138-42.
40. Roberts EA. Schilsky Ml. A practice guide line on Wilson
disease. Hepatology 2003; 37: 1475-92.
41. Deiss A, Lynch RE. Long-term therapy of Wilson’s disease.
Ann Intern Med 1971; 75:57-65.
42. El-Youssef M. Wilson disease. Mayo Clin Proc. 2003; 78:
1126-36.
43. Grand RJ. Juvenile Wilson disease: J Pediatr 1975; 87: 1161-
70.
44. Walshe JM. Treatment of Wilson’s disease with trientine.
Lancet 1982; i: 643-7.
45. Brewer GJ, Hill GM. Oral zinc therapy for Wilson’s disease.
Ann Intern Med 1983; 99: 314-9.
46. Brewer GJ. Treatment of Wilson disease with ammonium
tetrathiomolybdate. Arch Neurol 2003; 60: 379-85.
47. Kiss JE. Effective removal of copper by plasma exchange in
fulminant Wilson’s disease. Transfusion 1998; 38: 327-31.